Human Immune System Development and Rejection of Human Islet Allografts in Spontaneously Diabetic NOD-Rag1null IL2rγ Ins2Akita Mice

Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Diabetes (Impact Factor: 8.47). 09/2010; 59(9):2265-70. DOI: 10.2337/db10-0323
Source: PubMed

ABSTRACT To create an immunodeficient mouse model that spontaneously develops hyperglycemia to serve as a diabetic host for human islets and stem cell-derived beta-cells in the absence or presence of a functional human immune system.
We backcrossed the Ins2(Akita) mutation onto the NOD-Rag1(null) IL2rgamma(null) strain and determined 1) the spontaneous development of hyperglycemia, 2) the ability of human islets, mouse islets, and dissociated mouse islet cells to restore euglycemia, 3) the generation of a human immune system following engraftment of human hematopoietic stem cells, and 4) the ability of the humanized mice to reject human islet allografts.
We confirmed the defects in innate and adaptive immunity and the spontaneous development of hyperglycemia conferred by the IL2rgamma(null), Rag1(null), and Ins2(Akita) genes in NOD-Rag1(null) IL2rgamma(null) Ins2(Akita) (NRG-Akita) mice. Mouse and human islets restored NRG-Akita mice to normoglycemia. Insulin-positive cells in dissociated mouse islets, required to restore euglycemia in chemically diabetic NOD-scid IL2rgamma(null) and spontaneously diabetic NRG-Akita mice, were quantified following transplantation via the intrapancreatic and subrenal routes. Engraftment of human hematopoietic stem cells in newborn NRG-Akita and NRG mice resulted in equivalent human immune system development in a normoglycemic or chronically hyperglycemic environment, with >50% of engrafted NRG-Akita mice capable of rejecting human islet allografts.
NRG-Akita mice provide a model system for validation of the function of human islets and human adult stem cell, embryonic stem cell, or induced pluripotent stem cell-derived beta-cells in the absence or presence of an alloreactive human immune system.

Download full-text


Available from: Philip Diiorio, Jul 07, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fractional-N frequency synthesis has been introduced to alleviate integer-N Phase Locked Loop (PLL) frequency resolution problems as the requirement for fast switching time and low phase noise become increasingly stringent. Since its introduction, many Fractional-N PLL architectures have been implemented. However, these architectures, although they solve the frequency resolution issue, also generate other unwanted problems. It is the aim of this paper to outline those problems as well as provide a new fractional-N architecture that significantly alleviates the problems. The new architecture has been implemented in sub-micron RFCMOS technology. Measured phase noise results satisfy several cellular system requirements.
    Instrumentation and Measurement Technology Conference, 2002. IMTC/2002. Proceedings of the 19th IEEE; 02/2002
  • Pharmacology [?] Therapeutics 10/2010; 129(1):1-2. DOI:10.1016/j.pharmthera.2010.09.006 · 7.75 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human genetic studies have revealed the molecular basis of countless monogenic diseases but have been less successful in associating phenotype to genotype in complex multigenic conditions. Pluripotent stem cells (PSCs), which can differentiate into any cell type, offer promise for defining the functional effects of genetic variation. Here, we recount the advantages and practical limitations of coupling PSCs to genome-wide analyses to probe complex genetics and discuss the ability to investigate epigenetic contributions to disease states. We also describe new ways of using mice and mouse embryonic stem cells (ESCs) in tandem with human stem cells to further define genotype-phenotype relationships.
    Nature Reviews Genetics 03/2011; 12(4):266-75. DOI:10.1038/nrg2951 · 39.79 Impact Factor